1,6-bis(cyclohexyloximinocarbonyl)hexane has been researched along with Metabolic Diseases in 1 studies
1,6-bis(cyclohexyloximinocarbonyl)hexane: selective inhibitor of canine platelet diglyceride lipase
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janssen, FJ | 1 |
| van der Stelt, M | 1 |
1 review available for 1,6-bis(cyclohexyloximinocarbonyl)hexane and Metabolic Diseases
| Article | Year |
|---|---|
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders.
Topics: Animals; Arachidonic Acids; Endocannabinoids; Enzyme Inhibitors; Glycerides; Humans; Lipoprotein Lip | 2016 |